Works matching DE "CD30 antigen"

Results: 406

Histologic, Phenotypic, and Molecular Characterization of Feline Hodgkin‐Like Lymphoma With Classical Reed‐Sternberg Cells.

Published in:

2024

By:

Marconato, Laura;
Maga, Ilaria;
Iussich, Selina;
Benali, Silvia;
Aresu, Luca

Publication type:

Case Study

Alternating rabacfosadine and doxorubicin for treatment of naïve canine lymphoma.

Published in:

Veterinary & Comparative Oncology, 2024, v. 22, n. 2, p. 278, doi. 10.1111/vco.12975

By:

Saba, Corey F.;
Fan, Timothy M.;
Phillips, Brenda S.;
Wright, Zachary M.;
Thamm, Douglas H.

Publication type:

Article

Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping.

Published in:

Veterinary & Comparative Oncology, 2024, v. 22, n. 2, p. 303, doi. 10.1111/vco.12961

By:

Kambayashi, Satoshi;
Ono, Nanae;
Tone, Tomofumi;
Baba, Kenji;
Okuda, Masaru

Publication type:

Article

Efficacy and adverse events of continuous l‐asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin.

Published in:

Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 102, doi. 10.1111/vco.12749

By:

Nakagawa, Taisuke;
Kojima, Mari;
Ohno, Koichi;
Chambers, James K.;
Uchida, Kazuyuki;
Ohmi, Aki;
Goto‐Koshino, Yuko;
Tomiyasu, Hirotaka;
Tsujimoto, Hajime

Publication type:

Article

Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T‐cell lymphomas.

Published in:

Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 118, doi. 10.1111/vco.12752

By:

Azuma, Kazushi;
Ohmi, Aki;
Goto‐Koshino, Yuko;
Tomiyasu, Hirotaka;
Ohno, Koichi;
Chambers, James K.;
Uchida, Kazuyuki;
Namba, Hiroyuki;
Nagata, Masahiko;
Nagamine, Eiji;
Nibe, Kazumi;
Irie, Mitsuhiro;
Tsujimoto, Hajime

Publication type:

Article

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model.

Published in:

Veterinary & Comparative Oncology, 2021, v. 19, n. 1, p. 160, doi. 10.1111/vco.12656

By:

Bohannan, Zach;
Pudupakam, Raghavendra Sumanth;
Koo, Jamin;
Horwitz, Harrison;
Tsang, Josephine;
Polley, Amanda;
Han, Enyang James;
Fernandez, Elmer;
Park, Stanley;
Swartzfager, Deanna;
Qi, Nicholas Seah Xi;
Tu, Chantal;
Rankin, Wendi Velando;
Thamm, Douglas H.;
Lee, Hye‐Ryeon;
Lim, Sungwon

Publication type:

Article

Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials.

Published in:

Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 763, doi. 10.1111/vco.12605

By:

Saba, Corey F.;
Clifford, Craig;
Burgess, Kristine;
Phillips, Brenda;
Vail, David;
Wright, Zachary;
Curran, Katie;
Fan, Timothy;
Elmslie, Robyn;
Post, Gerald;
Thamm, Douglas

Publication type:

Article

Tyrosine Conjugation Methods for Protein Labelling.

Published in:

Chemistry - A European Journal, 2020, v. 26, n. 63, p. 14257, doi. 10.1002/chem.202001992

By:

Alvarez Dorta, Dimitri;
Deniaud, David;
Mével, Mathieu;
Gouin, Sébastien G.

Publication type:

Article

Elevation of tacrolimus concentration after administration of methotrexate for treatment of graft-versus-host disease in pediatric patients received allogeneic hematopoietic stem cell transplantation.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40780-023-00306-w

By:

Inoue, Chiaki;
Yamamoto, Takehito;
Miyata, Hiroshi;
Suzuki, Hiroshi;
Takada, Tappei

Publication type:

Article

Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.

Published in:

Clinical & Translational Immunology, 2021, v. 10, n. 4, p. 1, doi. 10.1002/cti2.1268

By:

Alvarez‐Fernández, Carmen;
Escribà‐Garcia, Laura;
Caballero, AC;
Escudero‐López, Eva;
Ujaldón‐Miró, Cristina;
Montserrat‐Torres, Rosanna;
Pujol‐Fernández, Paula;
Sierra, Jorge;
Briones, Javier

Publication type:

Article

Prognostic significance of CD30 expression in nasal natural killer/T-cell lymphoma.

Published in:

Oncology Letters, 2017, v. 13, n. 3, p. 1211, doi. 10.3892/ol.2017.5592

By:

GUAN-NAN WANG;
WU-GAN ZHAO;
LING LI;
DAN-DAN ZHANG;
XIAN-ZHENG GAO;
JUN ZHOU;
LEI ZHANG;
XIAO-RUI FU;
XIANG-YU ZHENG;
YE LI;
ZHEN LI;
MING-ZHI ZHANG;
WEN-CAI LI

Publication type:

Article

CD30+ extranodal natural killer/T-cell lymphoma mimicking phlegmonous myositis: A case report.

Published in:

2014

By:

YAN-JIA YANG;
YA-XIN LI;
YAN-BIN LIU;
MEI YANG;
KAI LIU

Publication type:

Case Study

Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brentuximab vedotin.

Published in:

Molecular & Clinical Oncology, 2021, v. 14, n. 6, p. N.PAG, doi. 10.3892/mco.2021.2283

By:

Milan, Elisa;
Miceli, Paola;
Sernicola, Alvise;
Finotto, Silvia;
Marino, Dario;
Alaibac, Mauro

Publication type:

Article

Prognostic Value of the Modified Systemic Inﬂammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.593392

By:

Huang, He;
Chen, Li Min;
Fang, Xiao Jie;
Guo, Cheng Cheng;
Lin, Xiao Ping;
Hong, Huang Ming;
Li, Xi;
Wang, Zhao;
Tian, Ying;
Chen, Mei Ting;
Yao, Yu Yi;
Chen, Zegeng;
Li, Xiao Qian;
Pan, Fei

Publication type:

Article

TEOA Inhibits Proliferation and Induces DNA Damage of Diffuse Large B-Cell Lymphoma Cells Through Activation of the ROS-Dependent p38 MAPK Signaling Pathway.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.554736

By:

Yu, Xingxing;
Wang, Xin;
Wang, Xu;
Zhou, Yi;
Li, Yanchun;
Wang, Aiwei;
Wang, Tongtong;
An, Yihan;
Sun, Weidong;
Du, Jing;
Tong, Xiangmin;
Wang, Ying

Publication type:

Article

Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 9, p. 1694, doi. 10.1111/ced.15262

By:

Hermans, Maud A. W.;
Pasmans, Suzanne G. M. A.;
Arends, Nicolette J. T.;
van den Bosch, Thierry P. P.;
van Daele, Paul L. A.;
van Doorn, Martijn B. A.;
Huisman, Elise J.;
Mooyaart, Antien L.;
Damman, Jeffrey

Publication type:

Article

CD30‐positive primary cutaneous anaplastic large cell lymphoma with coexistent pseudocarcinomatous hyperplasia.

Published in:

Clinical & Experimental Dermatology, 2018, v. 43, n. 5, p. 585, doi. 10.1111/ced.13416

By:

Kreuter, A.;
Pantelaki, I.;
Michalowitz, A.‐L.;
Wieland, U.;
Cerroni, L.;
Oellig, F.;
Tigges, C.

Publication type:

Article

Skin involvement as the first symptom of rapidly progressive ALK-positive systemic anaplastic large cell lymphoma.

Published in:

Clinical & Experimental Dermatology, 2017, v. 42, n. 5, p. 539, doi. 10.1111/ced.13146

By:

Yu, X.;
Zhang, J.;
Xu, K.;
Li, M.;
Yao, Z.

Publication type:

Article

Recent Advances in Understanding the Clinical Responses of Brentuximab Vedotin in Lymphoma and the Correlation with CD30 Expression.

Published in:

2025

By:

Chen, Wen;
Zhang, Zhihong

Publication type:

Literature Review

ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy.

Published in:

2016

By:

Chen Tian;
Yong Yu;
Hongliang Yang;
Lei Zhu;
Yafei Wang;
Yizhuo Zhang

Publication type:

Case Study

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.

Published in:

Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01436-6

By:

Chen, Jinghong;
Zuo, Zhixiang;
Gao, Yan;
Yao, Xiaosai;
Guan, Peiyong;
Wang, Yali;
Li, Zhimei;
Liu, Zhilong;
Hong, Jing Han;
Deng, Peng;
Chan, Jason Yongsheng;
Cheah, Daryl Ming Zhe;
Lim, Jingquan;
Chai, Kelila Xin Ye;
Chia, Burton Kuan Hui;
Pang, Jane Wan Lu;
Koh, Joanna;
Huang, Dachuan;
He, Haixia;
Sun, Yichen

Publication type:

Article

An Elusive Case of Mycosis Fungoides: Case Report and Review of the Literature.

Published in:

2019

By:

Pallazola, Vincent A.;
Deib, Gerard;
Abha, Soni;
Geha, Rabih M.;
Kobayashi, Kimiyoshi

Publication type:

journal article

CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.

Published in:

BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-890

By:

Pengfei Liu;
Li Jiangu;
Xinke Zhang;
Jun Liu;
Hua Wang

Publication type:

Article

CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.

Published in:

BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-890

By:

Pengfei Li;
Li Jiang;
Xinke Zhang;
Jun Liu;
Hua Wang

Publication type:

Article

Expression and Clinical Significance of CD30 and CD56 in Lymphoblastic Lymphoma: A Retrospective Analysis on Paraffin-Embedded Tissues by Immunohistochemistry.

Published in:

Fetal & Pediatric Pathology, 2024, v. 43, n. 2, p. 111, doi. 10.1080/15513815.2023.2301459

By:

Li, Shuqi;
Zheng, Shuang;
Huang, Xinyi;
Zhang, Wenhui;
Liu, Fang;
Cao, Qinghua

Publication type:

Article

Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series.

Published in:

Indian Journal of Dermatology, Venereology & Leprology, 2023, v. 89, n. 3, p. 403, doi. 10.25259/IJDVL_847_19

By:

Garzón, Eduardo;
Jairo Dávila-Rodríguez, John

Publication type:

Article

Solitary asymptomatic nodule on the leg.

Published in:

2016

By:

Almodovar-Real, Ana;
Aneiros-Fernandez, José;
Diaz-Martinez, Miguel A.;
Naranjo-Sintes, Ramón

Publication type:

journal article

Systemic anaplastic large cell lymphoma with secondary cutaneous involvement.

Published in:

2015

By:

Murkute, Amit S.;
Damle, Dhananjay K.;
Doshi, Bhavana R.;
Belgaumkar, Vasudha A.

Publication type:

Letter to the Editor

Expression of "DNA damage response" pathway genes in diffuse large B‐cell lymphoma: The potential for exploiting synthetic lethality.

Published in:

Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3225

By:

Mansoor, Adnan;
Kamran, Hamza;
Rizwan, Hassan;
Akhter, Ariz;
Roshan, Tariq Mahmood;
Shabani‐Rad, Meer‐Taher;
Bavi, Prashant;
Stewart, Douglas

Publication type:

Article

Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B‐cell lymphoma.

Published in:

Hematological Oncology, 2023, v. 41, n. 5, p. 828, doi. 10.1002/hon.3190

By:

Mansoor, Adnan;
Akhter, Ariz;
Shabani‐Rad, Meer‐Taher;
Deschenes, Jean;
Yilmaz, Asli;
Trpkov, Kiril;
Stewart, Douglas

Publication type:

Article

Orthotopic xenografts models in relapse/refractory lymphomas: a preclinical model for therapeutic, mechanistic and functional studies.

Published in:

Hematological Oncology, 2023, v. 41, p. 551, doi. 10.1002/hon.3164_412

By:

Domenech, E. Domingo;
Climent, F.;
Barca, E. Gonzalez;
de Lama, E.;
Lopez‐Pereira, P.;
Martinez‐Iniesta, M.;
Calaf, M.;
Oliveira, A.;
Montaner, C.;
Aguilera, C.;
Banda, E. de la;
Villanueva, A.;
Sureda, A.;
Farre, L.

Publication type:

Article

AFM13 enhances the anti‐tumor activity of AB‐101 towards CD30+ tumors, conferring tumor growth control in vivo.

Published in:

Hematological Oncology, 2023, v. 41, p. 559, doi. 10.1002/hon.3164_419

By:

Pahl, J.;
Haneke, T.;
Guerrettaz, L.;
Somanchi, S.;
Raymon, H.;
Pinto, S.;
Flynn, P.;
Koch, J.

Publication type:

Article

Safety and efficacy of brentuximab vedotin in Chinese adults with CD30+ peripheral T‐cell lymphoma: an interim analysis from a prospective, observational, real‐world study.

Published in:

Hematological Oncology, 2023, v. 41, p. 509, doi. 10.1002/hon.3164_376

By:

Cai, M.;
Cui, G.;
Liu, L.;
Li, Z.;
Bai, O.;
Lu, Y.;
Shi, K.;
Wang, J.;
Zhang, W.;
Zhao, W.

Publication type:

Article

CD30 protects EBV‐positive diffuse large B‐cell lymphoma cells against mitochondrial dysfunction through increasing BNIP3 expression.

Published in:

Hematological Oncology, 2023, v. 41, p. 256, doi. 10.1002/hon.3164_170

By:

Liang, J.;
Wang, W.;
Xing, T.;
Guo, J.;
Li, J.;
Xu, W.

Publication type:

Article

AFM13 IN PATIENTS WITH CD30 POSITIVE RELAPSED OR REFRACTORY (R/R) PERIPHERAL T CELL LYMPHOMA (PTCL): RESULTS FROM THE PHASE 2 REDIRECT STUDY.

Published in:

Hematological Oncology, 2023, v. 41, p. 195, doi. 10.1002/hon.3163_126

By:

Kim, W. S.;
Shortt, J.;
Zinzani, P. L.;
Mikhaylova, N.;
Marin‐Niebla, A.;
Radeski, D.;
Ribrag, V.;
Domenech, E. Domingo;
Sawas, A.;
Alexis, K.;
Emig, M.;
Garcia, L.;
Overesch, A.;
Pietzko, K.;
Horwitz, S.

Publication type:

Article

Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T‐cell lymphoma: A FIL phase 2 study.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 307, doi. 10.1002/hon.2963

By:

Stefoni, Vittorio;
Pellegrini, Cinzia;
Argnani, Lisa;
Corradini, Paolo;
Dodero, Anna;
Orsucci, Lorella;
Volpetti, Stefano;
Zinzani, Pier Luigi

Publication type:

Article

'NOT SO CLASSICAL': A STUDY OF THE IMMUNOPROFILE IN CLASSICAL HODGKIN LYMPHOMA, AN EXPERIENCE FROM A REFERRAL CENTER.

Published in:

Hematological Oncology, 2019, v. 37, p. 365, doi. 10.1002/hon.29_2631

By:

Das, M.;
Duggal, R.;
Dewan, A.;
Sharma, S.;
Jain, D.;
Narrendran, A.;
Prasad, S.;
Sethi, S.;
Kini, L.;
Mohanty, S.

Publication type:

Article

CD30‐CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR THERAPY OF HODGKIN LYMPHOMA (HL).

Published in:

Hematological Oncology, 2019, v. 37, p. 168, doi. 10.1002/hon.125_2629

By:

Ramos, C.A.;
Torrano, V.;
Bilgi, M.;
Gerken, C.;
Dakhova, O.;
Mei, Z.;
Wu, M.;
Grilley, B.;
Gee, A.P.;
Rooney, C.M.;
Dotti, G.;
Savoldo, B.;
Heslop, H.E.;
Brenner, M.K.

Publication type:

Article

'NOT SO CLASSICAL': A STUDY OF THE IMMUNOPROFILE IN CLASSICAL HODGKIN LYMPHOMA, AN EXPERIENCE FROM A REFERRAL CENTER.

Published in:

Hematological Oncology, 2019, v. 37, p. 365, doi. 10.1002/hon.29_2631

By:

Das, M.;
Duggal, R.;
Dewan, A.;
Sharma, S.;
Jain, D.;
Narrendran, A.;
Prasad, S.;
Sethi, S.;
Kini, L.;
Mohanty, S.

Publication type:

Article

CD30‐CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR THERAPY OF HODGKIN LYMPHOMA (HL).

Published in:

Hematological Oncology, 2019, v. 37, p. 168, doi. 10.1002/hon.125_2629

By:

Ramos, C.A.;
Torrano, V.;
Bilgi, M.;
Gerken, C.;
Dakhova, O.;
Mei, Z.;
Wu, M.;
Grilley, B.;
Gee, A.P.;
Rooney, C.M.;
Dotti, G.;
Savoldo, B.;
Heslop, H.E.;
Brenner, M.K.

Publication type:

Article

Corrigendum.

Published in:: 2012
Publication type:: Erratum

Aberrant expression and genetic alteration of c-MYC in anaplastic large cell lymphoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 1, p. 267, doi. 10.1007/s00432-021-03691-7

By:

Chen, Zhenwen;
Chai, Fei;
Xi, Yanfeng;
Zhang, Hongwei;
Xu, Yirong;
Zhang, Zhaoxia;
Li, Su;
Tian, Xiaoai

Publication type:

Article

Reduced frequency of cytotoxic CD56dim CD16+ NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 13, doi. 10.1007/s00262-021-02956-x

By:

Pánisová, Elena;
Lünemann, Anna;
Bürgler, Simone;
Kotur, Monika;
Lazarovici, Julien;
Danu, Alina;
Kaulfuss, Meike;
Mietz, Juliane;
Chijioke, Obinna;
Münz, Christian;
Busson, Pierre;
Berger, Christoph;
Ghez, David;
Azzi, Tarik

Publication type:

Article

CD30-targeted therapy induces apoptosis of inflammatory cytokine-stimulated synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice.

Published in:

Inflammation Research, 2022, v. 71, n. 2, p. 215, doi. 10.1007/s00011-021-01537-z

By:

Matsuhashi, Minami;
Nishida, Keiichiro;
Sakamoto, Misa;
Gion, Yuka;
Yoshida, Aki;
Katsuyama, Takayuki;
Nakahara, Ryuichi;
Nasu, Yoshihisa;
Matsumoto, Yoshinori;
Sato, Yasuharu;
Ozaki, Toshifumi

Publication type:

Article

Genetic and epigenetic instability in human pluripotent stem cells.

Published in:

Human Reproduction Update, 2013, v. 19, n. 2, p. 187, doi. 10.1093/humupd/dms048

By:

Nguyen, H.T.;
Geens, M.;
Spits, C.

Publication type:

Article

Pre-transplant soluble CD30 in combination with total DSA but not pre-transplant C1q-DSA predicts antibody-mediated graft loss in presensitized high-risk kidney transplant recipients.

Published in:

HLA: Immune Response Genetics, 2016, v. 87, n. 2, p. 89, doi. 10.1111/tan.12735

By:

Schaefer, S. M.;
Süsal, C.;
Opelz, G.;
Döhler, B.;
Becker, L. E.;
Klein, K.;
Sickmüller, S.;
Waldherr, R.;
Macher‐Goeppinger, S.;
Schemmer, P.;
Beimler, J.;
Zeier, M.;
Morath, C.

Publication type:

Article

A mutation panel comprising BRAFV600E, NRASQ61R, and NRASQ61H replicated retrospective histopathological examination findings in differentiating benign goitre from malignant papillary thyroid cancer in a cohort of Malaysian patients

Published in:

Malaysian Journal of Pathology, 2023, v. 45, n. 3, p. 375

By:

ENG, Zing Hong;
AHMAD JEFRY, Muhammad Muiz;
Khoon Leong NG;
ABDUL AZIZ, Azlina;
MAT JUNIT, Sarni

Publication type:

Article

Complete clinical response of a neglected cutaneous melanoma with combined radiotherapy and immunotherapy: A case report.

Published in:

Journal of Medical Radiation Sciences, 2021, v. 68, n. 1, p. 91, doi. 10.1002/jmrs.427

By:

Gorayski, Peter;
Dzienis, Marcin

Publication type:

Article

Relapse of Hodgkin's disease revealed by skin involvement.

Published in:

2022

By:

Abakarim, Ouadii;
Maghnouj, Oumaima;
Hamdaoui, Abderrachid;
Lahlimi, Fatima Zahra;
Tazi, Illias

Publication type:

Case Study

Extended use of brentuximab vedotin before autologous stem‐cell transplantation would benefit refractory systemic anaplastic large‐cell lymphoma.

Published in:

2018

By:

Koh, Youngil

Publication type:

Case Study